Mannatech (NASDAQ:MTEX) Issues Earnings Results

Mannatech (NASDAQ:MTEXGet Free Report) released its earnings results on Wednesday. The company reported $0.53 earnings per share for the quarter, FiscalAI reports. Mannatech had a negative return on equity of 2,383.34% and a negative net margin of 11.97%.The firm had revenue of $26.65 million for the quarter.

Mannatech Stock Up 3.5%

Shares of MTEX traded up $0.17 during trading hours on Wednesday, reaching $5.07. The stock had a trading volume of 297 shares, compared to its average volume of 21,909. Mannatech has a 52 week low of $3.80 and a 52 week high of $12.45. The firm has a 50-day moving average of $5.08 and a 200 day moving average of $5.76. The company has a market cap of $9.79 million, a P/E ratio of -0.76 and a beta of 0.73.

Insiders Place Their Bets

In other Mannatech news, Director Kevin Andrew Robbins bought 7,100 shares of Mannatech stock in a transaction on Tuesday, May 19th. The shares were purchased at an average cost of $4.17 per share, for a total transaction of $29,607.00. Following the completion of the acquisition, the director owned 33,333 shares in the company, valued at approximately $138,998.61. The trade was a 27.07% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at the SEC website. Insiders bought 14,903 shares of company stock worth $62,155 in the last 90 days. Insiders own 47.50% of the company’s stock.

Wall Street Analyst Weigh In

Separately, Weiss Ratings raised Mannatech from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Thursday, August 6th. One analyst has rated the stock with a Sell rating, According to MarketBeat.com, Mannatech currently has an average rating of “Sell”.

Check Out Our Latest Report on MTEX

Mannatech Company Profile

(Get Free Report)

Mannatech, Inc is a global health and wellness company that develops and markets a range of dietary supplements and personal care products through a direct selling business model. The company’s core focus is on glyconutrients, specialized carbohydrates believed to support cellular communication, which form the basis of many of its flagship offerings. Operating under a network marketing structure, Mannatech empowers independent associates to promote and distribute its products in markets around the world.

The company’s product portfolio includes nutritional supplements aimed at immune support, digestive health, and healthy aging, as well as skincare items designed to promote hydration and skin vitality.

Featured Stories

Earnings History for Mannatech (NASDAQ:MTEX)

Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.